Updated EU GMP guide on drug quality, outsourced activities to apply from 2013
This article was originally published in SRA
Executive Summary
The European Commission has revised its good manufacturing practice guideline with updated chapters on pharmaceutical quality and outsourced activities, and an updated annex on manufacturing of biological active substances1. The revisions to the guideline will apply from January 2013.
You may also be interested in...
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.